Postovariectomy Hypertension Is Linked to Increased Renal AT 1 Receptor and Salt Sensitivity
- 1 December 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 42 (6) , 1157-1163
- https://doi.org/10.1161/01.hyp.0000102180.13341.50
Abstract
The functional balance between angiotensin II (Ang II) and nitric oxide (NO) plays a key role in modulating salt sensitivity. Estrogen has been shown to downregulate angiotensin type 1 (AT 1 ) receptor expression and to increase the bioavailability of endothelium-derived NO, which decreases AT 1 receptor expression. The present study tests the hypothesis that in the presence of genetic salt sensitivity, deficiency of endogenous estrogens after ovariectomy (OVX) fosters an upregulation of Ang II. Female Dahl salt-resistant (DR), Dahl salt-sensitive (DS), Wistar-Kyoto (WKY), and spontaneously hypertensive (SHR) rats underwent bilateral OVX or sham surgery (SHX) and were fed a normal salt diet (0.5% NaCl) for 14 weeks. Systolic blood pressures were measured every 2 weeks and were not significantly different between OVX and SHX for DR, WKY, and SHR groups. However, at the end of 14 weeks of normal salt diet, hypertension developed in DS OVX but not SHX rats (160±3 versus 136±3 mm Hg; P 1 receptor blockade (119±3 mm Hg), or feeding a very low salt diet (0.1% NaCl; 129±4 mm Hg). Renal AT 1 receptor protein expression was significantly elevated 2-fold in DS OVX relative to SHX rats and was prevented by estrogen replacement. These data strongly suggest that after OVX in salt-sensitive rats there is a lower threshold for the hypertensinogenic effect of salt that is linked to an activation of Ang II.Keywords
This publication has 28 references indexed in Scilit:
- Angiotensin II type 1 receptor blockade to control blood pressure in postmenopausal women: Influence of hormone replacement therapyKidney International, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Cardiovascular Disease Outcomes During 6.8 Years of Hormone TherapyJAMA, 2002
- Renal AT1 Receptor Protein Expression During the Early Stage of Diabetes MellitusJournal of Diabetes Research, 2001
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- Postmenopausal hypertensionCurrent Hypertension Reports, 2000
- The Protective Effects of Estrogen on the Cardiovascular SystemNew England Journal of Medicine, 1999
- Salt sensitivity in hypertension. Renal and cardiovascular implications.Hypertension, 1994
- Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors.Hypertension, 1994
- Sodium and volume sensitivity of blood pressure. Age and pressure change over time.Hypertension, 1991